| Product Code: ETC13134154 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Peripheral Artery Disease Market was valued at USD 7.5 Billion in 2024 and is expected to reach USD 11.5 Billion by 2031, growing at a compound annual growth rate of 6.20% during the forecast period (2025-2031).
The Global Peripheral Artery Disease (PAD) market is experiencing steady growth driven by factors such as the rising prevalence of PAD, increasing geriatric population, and advancements in minimally invasive treatment options. The market includes a wide range of products such as stents, balloons, atherectomy devices, and peripheral vascular bypass surgery equipment. North America dominates the market due to high healthcare expenditure and awareness about PAD, followed by Europe, Asia-Pacific, and other regions. Key players in the market are investing in research and development to introduce innovative products and expand their market presence. However, challenges such as the high cost of treatment and the limited availability of skilled healthcare professionals in developing regions may hinder market growth to some extent.
The Global Peripheral Artery Disease (PAD) market is experiencing growth driven by increasing prevalence of PAD due to rising geriatric population and lifestyle factors. Technological advancements in minimally invasive procedures such as angioplasty and stenting are creating opportunities for market expansion. Furthermore, the growing awareness about early diagnosis and treatment of PAD is driving demand for innovative diagnostic tools and therapies. The market is also witnessing collaborations between key players to develop novel treatment options and expand their product portfolios. Additionally, the increasing healthcare expenditure in emerging economies is expected to fuel market growth. Overall, the PAD market presents promising prospects for companies involved in research, development, and commercialization of PAD-related products and services.
The Global Peripheral Artery Disease (PAD) market faces several challenges, including limited awareness about the disease among both patients and healthcare providers, leading to underdiagnosis and undertreatment. Additionally, the high cost of PAD treatment, especially in developing countries, poses a barrier to access for many patients. Another significant challenge is the complexity of PAD management, which often requires a multidisciplinary approach involving vascular specialists, cardiologists, and other healthcare professionals. Moreover, the competitive landscape in the PAD market is intense, with multiple companies vying for market share with innovative treatment options. Addressing these challenges will require concerted efforts to increase awareness, improve access to affordable treatment options, and enhance collaboration among healthcare providers to deliver comprehensive care for PAD patients worldwide.
The Global Peripheral Artery Disease (PAD) market is primarily driven by the increasing prevalence of PAD due to factors such as aging population, rising incidence of lifestyle-related diseases like diabetes and obesity, and growing awareness about the disease. Technological advancements in diagnostic tools and treatment options, such as minimally invasive procedures and drug-eluting stents, are also fueling market growth. Additionally, the expanding healthcare infrastructure in developing economies, along with government initiatives to improve access to healthcare services, are further contributing to the market expansion. Furthermore, the high demand for effective and innovative treatment solutions for PAD patients, coupled with the growing investments in research and development activities by key market players, are expected to drive the market in the coming years.
Government policies related to the Global Peripheral Artery Disease Market focus on improving access to healthcare services, promoting research and development of innovative treatments, and implementing strategies to raise awareness about the disease. Initiatives such as funding for clinical trials, support for medical device innovation, and guidelines for early detection and management play a crucial role in shaping the market for peripheral artery disease treatments. Additionally, regulatory measures to ensure the safety and efficacy of medical devices and pharmaceuticals in the treatment of peripheral artery disease are also significant factors influencing market dynamics. Overall, government policies aim to address the growing burden of peripheral artery disease by fostering a conducive environment for advancements in diagnosis, treatment, and patient care.
The Global Peripheral Artery Disease (PAD) market is expected to witness steady growth in the coming years driven by factors such as the rising prevalence of PAD due to lifestyle changes and aging populations, advancements in diagnostic technologies, and increasing awareness about the disease. The market is also likely to benefit from the development of innovative treatment options, including minimally invasive procedures and drug-eluting stents. Additionally, the increasing adoption of endovascular interventions and the growing focus on preventive healthcare measures are anticipated to contribute to market growth. However, challenges such as high treatment costs and limited access to healthcare facilities in certain regions could hinder market expansion. Overall, the Global PAD market is poised for growth, with opportunities for companies to capitalize on the evolving landscape and address the unmet needs of patients.
In the Global Peripheral Artery Disease (PAD) market, Asia is expected to witness significant growth due to the rising prevalence of PAD risk factors such as diabetes and obesity. North America is projected to dominate the market, driven by advanced healthcare infrastructure and high awareness about PAD. Europe is anticipated to show steady growth owing to increasing geriatric population and government initiatives for PAD management. In the Middle East and Africa region, the market is poised for growth due to improving healthcare facilities and rising awareness about PAD. Latin America is expected to experience moderate growth due to increasing healthcare expenditure and improving access to treatment options for PAD. Overall, the global PAD market is characterized by technological advancements, increasing prevalence of risk factors, and growing investments in research and development.
Global Peripheral Artery Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Peripheral Artery Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Peripheral Artery Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Peripheral Artery Disease Market - Industry Life Cycle |
3.4 Global Peripheral Artery Disease Market - Porter's Five Forces |
3.5 Global Peripheral Artery Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Peripheral Artery Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Peripheral Artery Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Peripheral Artery Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Peripheral Artery Disease Market Trends |
6 Global Peripheral Artery Disease Market, 2021 - 2031 |
6.1 Global Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Peripheral Artery Disease Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.1.3 Global Peripheral Artery Disease Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2 Global Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Peripheral Artery Disease Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.2.3 Global Peripheral Artery Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Peripheral Artery Disease Market, Overview & Analysis |
7.1 North America Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Peripheral Artery Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Peripheral Artery Disease Market, Overview & Analysis |
9.1 Asia Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Peripheral Artery Disease Market, Overview & Analysis |
10.1 Africa Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Peripheral Artery Disease Market, Overview & Analysis |
11.1 Europe Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Peripheral Artery Disease Market, Overview & Analysis |
12.1 Middle East Peripheral Artery Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Peripheral Artery Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Peripheral Artery Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Peripheral Artery Disease Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Peripheral Artery Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Peripheral Artery Disease Market Key Performance Indicators |
14 Global Peripheral Artery Disease Market - Export/Import By Countries Assessment |
15 Global Peripheral Artery Disease Market - Opportunity Assessment |
15.1 Global Peripheral Artery Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Peripheral Artery Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Peripheral Artery Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Peripheral Artery Disease Market - Competitive Landscape |
16.1 Global Peripheral Artery Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Peripheral Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |